VANCOUVER, British Columbia, July 12, 2012 /PRNewswire-Asia/ -- Pennystocksinsiders.com (PSI) has issued insider trading reports and Equity Research for the following companies: Freeport-McMoRan (NYSE: FCX), Bristol Myers Squibb (NYSE: BMY), Ciena (NASDAQ: CIEN), Beazer Homes (NYSE: BZH), CYS (NYSE: CYS), and ADTRAN (NASDAQ: ADTN).
(Read full report by clicking the link below, you may need to copy and paste the full link to your browser.)
Freeport-McMoRan Copper & Gold Inc. (NYSE: FCX): The Board of Directors of Freeport-McMoRan Copper & Gold Inc. (NYSE: FCX) declared a cash dividend of US$0.3125 per share. The dividend is payable on August 1, 2012 to shareholders of record on July 13, 2012. By the end of Wednesday's trading, Freeport-McMoRan, an international mining company, dropped US$0.42 per share (equivalent to 1.27%), where stock prices fell to US$32.36. Its low point in its 52-week range is US$28.85 per share, with US$56.78 as the 52-week high point. Freeport-McMoRan was traded above average volume with 23.80 million shares traded, 6.13 million shares more than its daily average. To boost investment return, Pennystocksinsiders.com refers insider trading data to professional investors as Freeport-McMoRan insiders have a better understanding about the future of the company. Do you want to know when Freeport-McMoRan insiders will buy their shares?
Read Full Report: http://www.Pennystocksinsiders.com/PR/071212A/FCX/FreeportMcMoRan.pdf
Bristol Myers Squibb Company (NYSE: BMY): Bristol Myers Squibb Company (NYSE: BMY) started a cash tender offer to acquire all outstanding shares of common stock of Amylin Pharmaceuticals, Inc. for about US$5.3 billion in cash. The tender offer will expire at 5:00 p.m. New York time on August 7, 2012. Shares of Bristol Myers Squibb continued to slide on Wednesday and closed lower by US$0.13 (or -0.37%) at US$34.59 with more than 9.03 million shares exchanged hands for the session compared to its average volume of 11.21 million shares. The stock's low point in its 52-week range is US$25.69 per share, with US$36.34 as the 52-week high point. Bristol Myers Squibb is a global biopharmaceutical company with a market capitalization of US$58.21 billion. Are Bristol Myers Squibb insiders starting to take huge profits by selling shares or exercising stock options? Academic studies have approved that insiders traditionally make higher investment returns than ordinary investors.
Read Full Report: http://www.Pennystocksinsiders.com/PR/071212A/BMY/BristolMyersSquibb.pdf
Ciena Corporation (NASDAQ: CIEN): Pennystocksinsiders.com found Market Sale (Planned) made by company President, Chief Executive Officer, Director -- Gary B. Smith on July 6, at stock price US$15.70. Disclose date: July 10. In the last trading session, Ciena Corporation (NASDAQ: CIEN) slumped US$1.21 (-7.88%) to US$14.15 with significant volume traded, which was 2 times more than average volume. Ciena Corporation has a market capitalization of US$1.40 billion. Are you interested in the non-public stock trading behaviors of Ciena insiders? Investors can get the information they need by clicking the following link.
Read Full Report: http://www.Pennystocksinsiders.com/PR/071212A/CIEN/Ciena.pdf
Today Pennystocksinsiders.com also observed abnormal trade volume for the following companies; insiders may involve trading in these companies. It will take some time for insiders to report their trades. Read these reports and add these companies into your Insider Trade Radar.
Beazer Homes USA, Inc. (NYSE: BZH):
Read Full Report: http://www.Pennystocksinsiders.com/PR/071212A/BZH/BeazerHomes.pdf
CYS Investments Inc. (NYSE: CYS):
Read Full Report: http://www.Pennystocksinsiders.com/PR/071212A/CYS/CYS.pdf
ADTRAN, Inc. (NASDAQ: ADTN):
Read Full Report: http://www.Pennystocksinsiders.com/PR/071212A/ADTN/ADTRAN.pdf
Insider Filing Source Reference: All observations, analysis and reports are based on public information released by the U.S. Securities and Exchange Commission.
Pennystocksinsiders.com features a team of experienced data analysts striving to provide the investment community with the tools, software, and data necessary to carry out more effective investment research.
Please visit Pennystocksinsiders.com/disclaimers/index.php for details.